$70,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Health care policy issues."
You can find more data on corporate lobbying on Quiver Quantitative.
CVS Congressional Stock Trading
Members of Congress have traded $CVS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CVS stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 01/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
CVS Insider Trading Activity
CVS insiders have traded $CVS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CVS stock by insiders over the last 6 months:
- LARRY ROBBINS has made 0 purchases and 7 sales selling 3,372,000 shares for an estimated $317,471,136.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CVS Hedge Fund Activity
We have seen 820 institutional investors add shares of CVS stock to their portfolio, and 845 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 12,200,134 shares (-44.2%) from their portfolio in Q1 2026, for an estimated $870,723,563
- DODGE & COX removed 10,729,872 shares (-17.2%) from their portfolio in Q1 2026, for an estimated $765,790,964
- FMR LLC removed 9,821,091 shares (-23.9%) from their portfolio in Q1 2026, for an estimated $700,931,264
- CAPITAL WORLD INVESTORS added 9,585,731 shares (+14.2%) to their portfolio in Q1 2026, for an estimated $684,133,621
- CAPITAL RESEARCH GLOBAL INVESTORS added 7,968,909 shares (+66.2%) to their portfolio in Q1 2026, for an estimated $568,741,035
- PRICE T ROWE ASSOCIATES INC /MD/ added 7,339,159 shares (+44.6%) to their portfolio in Q1 2026, for an estimated $523,795,777
- BLACKROCK, INC. added 4,925,379 shares (+4.1%) to their portfolio in Q1 2026, for an estimated $351,524,299
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CVS Price Targets
Multiple analysts have issued price targets for $CVS recently. We have seen 17 analysts offer price targets for $CVS in the last 6 months, with a median target of $106.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $113.0 on 07/09/2026
- Sarah James from Cantor Fitzgerald set a target price of $110.0 on 07/07/2026
- Allen Lutz from B of A Securities set a target price of $110.0 on 06/23/2026
- Ann Hynes from Mizuho set a target price of $115.0 on 06/08/2026
- Erin Wright from Morgan Stanley set a target price of $111.0 on 06/04/2026
- David Macdonald from Truist Securities set a target price of $108.0 on 06/01/2026
- Andrew Mok from Barclays set a target price of $106.0 on 05/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
